Comparison of Plasma Viscosity Following Administration of Albumin 5% in Half-Normal Saline versus Normal Saline during Minor Surgeries
AbstractBackground: We aimed to compare the effect of albumin 5% in half normal saline (half NS) versus normal saline (NS) infusion on the plasma viscosity in the near-normal physiological condition. According to the high oncotic pressure of albumin along with prolonged half-life of its molecules in comparison to NS in the intra-vascular compartment, it has been proposed that a more significant reduction of the plasma viscosity might be expected after the infusion of albumin.Methods: A total of 56 patients referring to the general operating room for their elective minor surgeries were evenly divided into two groups (V1, V2). It was calculated that 28 patients were needed to be enroll in each study group to detect a difference as big as 0.15 millipoise (mPa.s) with a statistical power of 80%. The V1 group received 1000 ml of NS but the V2 group received 1000 ml of recombinant albumin 5% in half NS within one hour, as fluid replacement therapy, during the intra-operative period. We have designed a simple measurement system according to Poiseuille’s formula by which the viscosity value could be measured reliably since the system was calibrated frequently using distilled water as a reference.Results: The mean value of the pre-operative plasma viscosity of the patients was 1. 73 ± 0.25 mPa.s and 1.76 ± 0.21 mPa.s in V1 and V2 groups respectively. After the infusion of the fluids, the mean viscosity values decreased to 1. 68 ± 0.30 mPa.s and 1.66 ± 0.17mPa.s in V1 and V2 groups respectively (p= 0.37).
Edwards MR, Grocott MPW: Perioperative Fluid and Electrolyte Therapy. In: Miller RD, Cohen NH, Eriksson LI, Fleisher LA, Wiener-Kronish JP and Young WL. (Eds.) Miller’s Anesthesia, 8th Ed. Elsevier Saunders, Philadelphia 2015; 1800.
Pop GA, Bisschops LL, Iliev B, Struijk PC, van der Hoeven JG, Hoedemaekers CW. On-line blood viscosity monitoring in vivo with a central venous catheter, using electrical impedance technique. Biosens Bioelectron. 2013; 41:595-601.
Reinhart WH. Molecular biology and self-regulatory mechanisms of blood viscosity: a review. Biorheology. 2001; 38(2-3):203-12.
Gul R, Karis D, Koksal GM, Sayilgan C, Bolayirly M, Oz H, et al. Effects of sevoflurane and desflurane on the blood and plasma viscosity. Medical Science and Discovery. 2015; 2(2):165-170.
Kul AN, Ozdemir S, Helvaci A, Bulut C, Dursun S. The Relationship of Acute Myocardial Infarction With or Without ST-Segment Elevation and Viscosity. Clin Appl Thromb Hemost. 2014; 20(8):779-82.
Sapmaz I, Saba T, Haberal C, Toktamis A, Cakmak M, Cicek D. Fibrinogen-Albumin Ratio: An Intriguing Relationship for Assessing Trombosis Risk and Suspicious Effect on Blood viscosity. Iraninan Cardivascular Research Journal. 2011; 5(4):153-4.
Grotemeyer KC, Kaiser R, Grotemeyer KH, Husstedt IW. Association of elevated plasma viscosity with small vessel occlusion in ischemic cerebral disease. Thromb Res. 2014; 133(1):96–100.
Aras S, Tek I, Varli M, Yalcin A, Cengiz OK, Atmis V, et al. Plasma Viscosity: Is Biomarker for the Differential Diagnosis of Alzheimer’s Disease and Vascular Dementia? Am J Alzheimers Dis Other Demen. 2013; 28(1):62-8.
Konstantinova E, Tolstaya T, Prishchep S, Milutin A, Mironova E, Ivanova L. Plasma lipid levels, blood rheology, platelet aggregation, microcirculation state and oxygen transfer to tissues in young and middle-aged healthy people. Clin Hemorheol Microcirc. 2004; 30(3-4):443-8.
Replogle RL, Meiselman HJ, Merrill EW. Clinical implications of blood rheology studies. Circulation. 1967; 36(1):148-60.
Koenig W, Sund M, Filipiak B, Doring A, Lowel H, Ernst E. Plasma viscosity and the risk of coronary heart disease: results from the MONICA-Augsburg Cohort Study, 1984 to 1992. Arterioscler Thromb Vasc Biol. 1998; 18(5):768-72.
Lowe G, Rumley A, Norrie J, Ford I, Shepherd J, Cobbe S, et al. Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost. 2000; 84(4):553-8.
Kesmarky G, Toth K, Habon L, Vajda G, Juricskay I. Hemorheological parameters in coronary artery disease. Clin Hemorheol Microcirc. 1998; 18(4):245-51.
Levine GN, Keaney JF Jr, Vita JA. Cholesterol reduction in cardiovascular disease. Clinical benefits and possible mechanisms. N Engl J Med. 1995; 332(8):512-21.
Treasure CB, Klein JL, Weintraub WS, Talley JD, Stillabower ME, Kosinski AS, et al. Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease. N Engl J Med. 1995; 332(8):481-7.
Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease.The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991; 83(3):836-44.
Lowe GD, Lee AJ, Rumley A, Price JF, Fowkes FG. Blood viscosity and risk of cardiovascular events: the Edinburgh Artery Study. Br J Haematol.1997; 96(1):168-73.
Evans PA, Heptinstall S, Crowhurst EC, Davies T, Glenn JR, Madira W, et al. Prospective double-blind randomized study of the effects of four intravenous fluids on platelet function and hemostasis in elective hip surgery. J Thromb Haemost. 2003; 1(10): 2140-8.
Cabrales P, Nacharaju P, Manjula BN, Tsai AG, Acharya SA, Intaglietta M. Early difference in tissue pH and microvascular hemodynamics in hemorrhagic shock resuscitation using polyethylene glycol-albumin- and hydroxyethyl starch-based plasma expanders. Shock. 2005; 24(1):66-73.
Muir WW 3rd, Kijtawornrat A, Ueyama Y, Radecki SV, Hamlin RL. Effects of intravenous administration of lactated Ringer's solution on hematologic, serum biochemical, rheological, hemodynamic, and renal measurements in healthy isoflurane-anesthetized dogs. J Am Vet Med Assoc. 2011; 239(5):630-7.
Messmer C, Yalcin O, Palmer AF, Cabrales P. Small-volume resuscitation from hemorrhagic shock with polymerized human serum albumin. Am J Emerg Med. 2012; 30(8):1336-46.
Hensel M, Wrobel R, Volk T, Pahlig H, Kox WJ. [Changes in coagulation physiology and rheology after preoperative normovolemic hemodilution]. Anasthesiol Intensivmed Notfallmed Schmerzther. 1996; 31(8):481-7.
Freyburger G, Dubreuil M, Boisseau MR, Janvier G. Rheological properties of commonly used plasma substitutes during preoperative normovolaemic acute haemodilution. Br J Anaesth. 1996; 76(4): 519-25.
Tullis JL. Albumin. 1. Background and use. JAMA. 1 1977; 237(4):355-60.
Rivers EP, Jaehne AK, Eichhorn-Wharry L, Brown S, Amponsah D. Fluid therapy in septic shock. Curr Opin Crit Care. 2010; 16(4): 297-308.
Boldt J. Use of albumin: an update. Br J Anaesth. 2010; 104(3):276-84.
Baieth HE. Physical parameters of blood as a non - newtonian fluid. Int J Biomed Sci. 2008; 4(4):323-9.
Leonhardt H, Arntz HR, Klemens UH. Studies of plasma viscosity in primary hyperlipoproteinaemia. Atherosclerosis. 1977; 28(1):29-40.
Blann A, Bignell A, McCollum C. von Willebrand factor, fibrinogen and other plasma proteins as determinants of plasma viscosity. Atherosclerosis. 1998; 139(2):317-22.
Haidekker MA, Tsai AG, Brady T, Stevens HY, Frangos JA, Theodorakis E, et al. A novel approach to blood plasma viscosity measurement using fluorescent molecular rotors. Am J Physiol Heart Circ Physiol. 2002; 282(5): H1609-14.
Kesmarky G, Kenyeres P, Rabai M, Toth K. Plasma viscosity: a forgotten variable. Clin Hemorheol Microcirc. 2008; 39(1-4):243-6.
Vlastos GA, Tangney CC, Rosenson RS. Effects of hydration on blood rheology. Clin Hemorheol Microcirc. 2003; 28(1): 41-9.
Eckmann DM, Bowers S, Stecker M, Cheung AT. Hematocrit, volume expander, temperature, and shear rate effects on blood viscosity. Anesth Analg. 2000; 91(3):539-45.